These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389 [TBL] [Abstract][Full Text] [Related]
26. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention. Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538 [TBL] [Abstract][Full Text] [Related]
27. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin]. Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130 [TBL] [Abstract][Full Text] [Related]
28. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies. Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862 [TBL] [Abstract][Full Text] [Related]
29. Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India. Oommen SK; Appalaraju B; Jinsha K Indian J Med Microbiol; 2010; 28(4):372-5. PubMed ID: 20966573 [TBL] [Abstract][Full Text] [Related]
30. Intranasal mupirocin to prevent postoperative infections. von Eiff C; Kipp F; Becker K N Engl J Med; 2002 Oct; 347(15):1207-8; author reply 1207-8. PubMed ID: 12374887 [No Abstract] [Full Text] [Related]
31. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881 [TBL] [Abstract][Full Text] [Related]
32. Current options for the treatment of impetigo in children. Sladden MJ; Johnston GA Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885 [TBL] [Abstract][Full Text] [Related]
33. Use of nasal mupirocin for eradicating meticillin-resistant Staphylococcus aureus: a dilemma? Afghani B; Kong V; Wu FL J Hosp Infect; 2006 Nov; 64(3):299-300. PubMed ID: 16979263 [No Abstract] [Full Text] [Related]
34. [Managing children skin and soft tissue infections]. Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857 [TBL] [Abstract][Full Text] [Related]
35. Dynamic of nasal colonization by methicillin-resistant Staphylococcus aureus ST398 and ST1 after mupirocin treatment in a family in close contact with pigs. Lozano C; Aspiroz C; Lasarte JJ; Gómez-Sanz E; Zarazaga M; Torres C Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):e1-7. PubMed ID: 20663559 [TBL] [Abstract][Full Text] [Related]
36. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705 [TBL] [Abstract][Full Text] [Related]
38. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
39. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. Cookson BD J Antimicrob Chemother; 1998 Jan; 41(1):11-8. PubMed ID: 9511032 [TBL] [Abstract][Full Text] [Related]